Adaptive Biotechnologies Earnings & Forecasts

Adaptive Biotechnologies (ADPT) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 29, 2026	$-0.10	$-0.13	23.1 %
Q1	May 5, 2026	$-0.13	$-0.16	18.8 %
Q4	Feb 5, 2026	$-0.09	$-0.19	52.6 %
Q3	Nov 5, 2025	$-0.15	$-0.15	0.00 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 29, 2026	$71.55M	$66.08M	8.29 %
Q1	May 5, 2026	$70.87M	$61.07M	16.1 %
Q4	Feb 5, 2026	$71.68M	$60.90M	17.7 %
Q3	Nov 5, 2025	$60.20M	$66.00M	-8.78 %

Adaptive Biotechnologies Guidance

Adaptive Biotechnologies (ADPT)는 1월 12, 2026에 fiscal year 2025에 대한 가이던스를 마지막으로 발표했습니다. 회사는 해당 기간의 매출을 $277M - $277M 범위로 예상했습니다.

이전 가이던스와 비교하여 Adaptive Biotechnologies는 매출 전망치를 이전 범위인 상향 조정됨에서 $72M - $72M로 상향 조정했습니다.

Adaptive Biotechnologies은 9과 11월 3, 2022 사이에 1월 12, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 4 times and lowered it 2 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$-0.13	$-0.16	$-0.19	$-0.15
Actual	$-0.10	$-0.13	$-0.09	$-0.15
Surprise	+23.1%	+18.8%	+52.6%	0.00%
Revenue
Estimate	$66.1M	$61.1M	$60.9M	$66.0M
Actual	$71.6M	$70.9M	$71.7M	$60.2M
Surprise	+8.29%	+16.1%	+17.7%	-8.78%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$-0.10	$-0.06	$-0.08	$-0.05
Revenue
Consensus	$71.8M	$79.1M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
UPDATE: Adaptive Biotechnologies Q2 Adj. EPS $(0.10) Beats $(0.13) Estimate, Sales $71.553M Beat $65.886M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 41.18 percent increase over losses of $(0.17) per

Benzinga Newsdesk

PRO
Adaptive Biotechnologies Q2 EPS $(0.25) Misses $(0.14) Estimate, Sales $71.553M Beat $65.886M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.14) by 78.57 percent. This is a 47.06 percent decrease over losses of $(0.17) per

Benzinga Newsdesk

Stock Market Today: S&P 500, Nasdaq Futures Fall, Dow Gains Amid US-Iran Deal— SpaceX, Dave And Buster's, Western Digital In Focus (UPDATED)

(Editor’s note: The lede, headline, futures and economic data were updated.) U.S. stock futures were mixed on Tuesday, as the Dow Jones rose, while the Nasdaq 100 and S&P 500 declined, following Monday’s rally. The Labor Department reported that U.S. import prices advanced 1.9% in May, driven by surging fuel costs.

Rishabh Mishra

Adaptive Biotechnologies Corp